Cellular Engineering for the Treatment of Metabolic Disorders: Prospects for Therapy in Diabetes
- 1 October 1992
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 10 (10) , 1112-1120
- https://doi.org/10.1038/nbt1092-1112
Abstract
Significant advances in the areas of identification of disease susceptibility genes and gene transfer technologies have fueled new initiatives in cellular engineering as a means for treating metabolic disease. This article utilizes new findings from such work as the blueprint for a discussion of the prospects for gene therapy in diabetes mellitus.Keywords
This publication has 48 references indexed in Scilit:
- Treatment of Severely Diabetic Pancreatectomized Dogs Using a Diffusion-Based Hybrid PancreasDiabetes, 1992
- Human gene therapy comes of ageNature, 1992
- Maintenance of Normoglycemia in Diabetic Mice by Subcutaneous Xenografts of Encapsulated IsletsScience, 1991
- Biohybrid Artificial Pancreas: Long-Term Implantation Studies in Diabetic, Pancreatectomized DogsScience, 1991
- Induction of Donor-Specific Unresponsiveness by Intrathymic Islet TransplantationScience, 1990
- Clinical application of somatic gene therapy in inborn errors of metabolismJournal of Inherited Metabolic Disease, 1990
- Establishment of a Pancreatic β Cell Line That Retains Glucose-Inducible Insulin Secretion: Special Reference to Expression of Glucose Transporter Isoforms*Endocrinology, 1990
- Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene.Proceedings of the National Academy of Sciences, 1988
- Islet Transplantation in Treating DiabetesAnnual Review of Medicine, 1986
- A transplantable insulinoma in the rat.Proceedings of the National Academy of Sciences, 1977